Cyclerion Therapeutics, Inc. Share Price

Cyclerion Therapeutics, Inc. Share Price

NASDAQ: CYCN
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cyclerion Therapeutics, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Cyclerion Therapeutics, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Cyclerion Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-10.03
Revenue (TTM)
$2.07B
Return On Equity (TTM)
-131.85%
Profit Margin
-170.53%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-79.59%

Cyclerion Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.88$1.03$0.00$0.00
Net Profit-$0.98-$0.80-$3.18-$1.76
Net Profit Margin-111.36%-77.67%N/AN/A
Income ChangeN/A18.37%-297.50%44.65%

Cyclerion Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.30$0.00$2.00$2.07
Net Profit-$44.08-$5.26-$3.06-$3.53
Net Profit Margin-14693.33%N/A-153.00%-170.53%
Income ChangeN/A88.07%41.83%-15.36%

About Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Cyclerion Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

CYCN Share Price FAQs